{"id":4298,"date":"2023-08-08T20:51:41","date_gmt":"2023-08-09T01:51:41","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=4298"},"modified":"2023-08-08T20:54:43","modified_gmt":"2023-08-09T01:54:43","slug":"uk-health-security-agency-unveils-world-leading-vaccine-development-and-evaluation-centre","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2023\/08\/08\/uk-health-security-agency-unveils-world-leading-vaccine-development-and-evaluation-centre\/","title":{"rendered":"UK Health Security Agency unveils world-leading Vaccine Development and Evaluation Centre"},"content":{"rendered":"
\n

Medical News.Net<\/a><\/p>\n\n\n\n

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.<\/p>\n\n\n\n

The center is situated at the UKHSA’s Porton Down site, where it is co-located with other services delivered separately by partners including the Defence Science and Technology Laboratory.<\/p>\n\n\n\n

The creation of the center, in over 2,800 square meters of laboratory space at Porton Down, is a major part of UKHSA’s 3-year strategy and incorporates over 200 leading scientists working on around 100 wide-ranging projects, including tackling deadly pathogens with pandemic potential.<\/p>\n\n\n\n

Its work involves supporting the development of new vaccines by testing and evaluating them against threats capable of causing a health emergency. The Centre’s work is conducted throughout the vaccine lifecycle, from early in the vaccine product design through to evaluating vaccine effectiveness, which continues when new variants arise.<\/p>\n\n\n\n

In particular, the center will target pathogens for which a vaccine does not exist or is not regulated in the UK, or could be improved, such as avian influenza, mpox (monkeypox) or hantavirus, a severe infection that can pass from rodents to humans.<\/p>\n\n\n\n

In one example of its work, VDEC’s teams are already running phase one clinical trials for what could be a world-first vaccine against Crimean-Congo hemorrhagic fever, a virus that is spread by the bite of an infected tick and is sadly fatal in about 30% of cases.<\/p>\n\n\n\n

They are also targeting common infections like tuberculosis (TB) and Clostridium difficile, a bacterial infection that can cause significant problems in healthcare settings.<\/p>\n\n\n\n

Building on capabilities developed during the COVID-19 pandemic to test emerging vaccines against new variants, VDEC has been created to take that work forward and expand its remit to a wide range of other deadly pathogens and diseases.<\/p>\n\n\n\n

The center has a unique set of capabilities specializing in high consequence infectious diseases and working to the highest standards of safety, quality and security, making its research and outputs trusted worldwide.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Medical News.Net The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide. The center is situated at the UKHSA’s Porton Down site, where it is co-located with other services delivered separately […]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[8],"tags":[],"class_list":["post-4298","post","type-post","status-publish","format-standard","hentry","category-vaccine-headlines"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/4298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=4298"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/4298\/revisions"}],"predecessor-version":[{"id":4299,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/4298\/revisions\/4299"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=4298"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=4298"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=4298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}